Medline Inc. (MDLN)
Medline is a manufacturer and distributor of medical supplies; its Prime Vendor agreements had an average mix of about 65% Supply Chain Solutions and 35% Medline Brand at December 31, 2025.
| Ticker | MDLN |
|---|
| Company | Medline Inc. |
|---|
| Exchange | Nasdaq |
|---|
| Headquarters | NORTHFIELD, IL |
|---|
Income statement — period ending 2026-06-27
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $36,000,000 |
|---|
| Cost of Goods and Services Sold | $5,470,000,000 |
|---|
| Earnings Per Share, Basic | 0 USD/shares |
|---|
| Earnings Per Share, Diluted | 0 USD/shares |
|---|
| Gross Profit | $2,215,000,000 |
|---|
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $235,000,000 |
|---|
| Income Tax Expense (Benefit) | $96,000,000 |
|---|
| InterestExpenseNonoperating | $168,000,000 |
|---|
| Investment Income, Interest | $49,000,000 |
|---|
| Net Income (Loss) Attributable to Noncontrolling Interest | $79,000,000 |
|---|
| Net Income (Loss) Available to Common Stockholders, Basic | $59,000,000 |
|---|
| Nonoperating Income (Expense) | -$160,000,000 |
|---|
| Operating Expenses | $1,820,000,000 |
|---|
| Operating Income (Loss) | $395,000,000 |
|---|
| Other Nonoperating Income (Expense) | -$42,000,000 |
|---|
| Other Operating Income (Expense), Net | -$348,000,000 |
|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $139,000,000 |
|---|
| Revenues | $7,685,000,000 |
|---|
| Selling, General and Administrative Expense | $1,295,000,000 |
|---|
| Share-based Payment Arrangement, Noncash Expense | $52,000,000 |
|---|
| Weighted Average Number of Shares Outstanding, Diluted | 860,890,719 shares |
|---|
| Weighted Average Number of Shares Outstanding, Basic | 856,671,262 shares |
|---|
Sourced from SEC EDGAR/XBRL filings via StockSpectro.
View full interactive research on StockSpectro